“According to the research report published by Polaris Market Research, the Global Viscosupplementation Market Is Estimated To Reach USD 6.47 Billion By 2028, at a CAGR of 9.1% during the forecast period.”
Overview:
Global viscosupplementation market has been witnessing advent of combination therapeutic products, which is already utilized in treatment of various diseases. These products have been relatively new entrants in viscosupplement palliative knee osteoarthritis treatment which offers promising future prospects.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market-specific growth opportunities in global viscosupplementation market.
Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market/request-for-sample
Top Global Market Players:
- Anika Therapeutics Inc.
- Sanofi
- Zimmer Holdings Inc.
- Lifecore Biomedical LLC
- LG Life Sciences Limited
- Bioventus
- Ferring B.V
- Salix Pharmaceuticals Inc.
- Fidia Farmaceutici S.p.A.
- F. Hoffmann-La Roche AG.
Covid-19 Pandemic: Viscosuppplementation Market Players Consolidating their Position:
The ongoing Covid-19 pandemic has compelled the market players to take a consistent path for the next two quarters. As it would take some time for the healthcare vertical to look through new product launches; the players are looking at ways to smoothen the supply chain as manpower has taken a hit.
Request for Discounted Price on this Report @ https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market/request-for-discount-pricing
Key Trends:
- While knee osteoarthritis shall continue generating the largest revenue share, efforts are underway to develop novel products addressing hip and elbow joint problems as well
- Vegan-based viscosupplementation injections are gaining fast traction, such as the MONOVISC series developed by Ankia Therapeutics. It received FDA approval during the first half of 2014
- Development of single injection hyaluronic acid supplements will further stimulate the viscosupplementation market
By Region:
Regional analysis is done across North America, Europe and Asia Pacific region. The US is the worlds leading market for osteoarthritis treatment, both for viscosupplementation and steroid injections. Future forecasts of the market overall and across various regions till 2025 is provided in the report. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Enquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market/inquire-before-buying
FAQs About viscosupplementation market:
- What are the key players in the viscosupplementation market?
- What is the growth rate of the market?
- How big is the viscosupplementation market?
- How much will the viscosupplementation industry share grow during the forecast timeline?
About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
Contact Us:
Polaris Market Research
Phone: +1-929-297-9727
Email: [email protected]
The Viscosupplementation Market 2021 research report gives emerging industry data, global segments and regional outlook.
This report covers up all details such as size, share, value, growth, restraints, and opportunities for the year 2020 to 2027.
The report generated using various analysis tools like porter’s five forces model, market attractiveness and value chain.
The report gives comprehensive review of the global market helping to club revenue generation and profitable business to transform client’s success.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the viscosupplementation market include Sanofi, Anika Therapeutics, Inc., Seikagaku Corporation, Zimmer Holdings Inc., Bioventus, Ferring B.V., Lifecore Biomedical, LLC, and LG Life Sciences Ltd.S.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Viscosupplementation Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/viscosupplementation-market/download-sampleMarket DynamicsThe increased preference for nonsurgical procedures for long-lasting pain relief and mobility restoration in osteoarthritis patients will be the few essential elements favoring this market's growth.
The global viscosupplementation market size is expected to reach USD 7.8 billion by 2027, based on a new report published by Radiant Insights, Inc.
Factors, such as the growing awareness regarding effective non-surgical procedures for the management of OA and global increase in the target population due to the increasing prevalence of obesity and other lifestyle-induced disorders, are expected to propel the market growth during the forecast period.
Download Free Sample Report @ https://www.radiantinsights.com/research/viscosupplementation-market/request-sample Further key findings from the study suggest: • Three injections segment dominated the market in 2019 owing to the availability of multiple products and significant market presence • Single injection segment is anticipated to witness the fastest growth during the forecast period owing to the increase in demand for a shorter regimen of procedures and faster recovery time • The utilization of viscosupplementation is maximum in Ambulatory Surgical Centers (ASCs), and orthopedic clinics.
The higher usage of the viscosupplements is observed to be in outpatient settings owing to better reimbursement options • General physicians, rheumatologists, and orthopedists are the main influencer in the viscosupplementation market.
The role of an influencer in the procurement of the product in the hospitals and clinics varies from region to region • Asia Pacific held the largest market share in 2019 and is expected to maintain its position during the forecast period due to the presence of key players and high incidence of osteoarthritis in the countries such as Japan and China.
• Europe is expected to witness a lucrative CAGR in the forthcoming years, due to growing awareness about applications of non-surgical techniques and increasing disposable income • Key players are investing in improving their product portfolio to develop advanced products to maintain their market position.
